Quipt Home Medical Corp.
QIPT · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -8.88 | -0.05 | 0.46 | -0.12 |
| FCF Yield | 5.69% | 7.29% | 4.28% | 2.64% |
| EV / EBITDA | 15.84 | 15.57 | 16.37 | 17.72 |
| Quality | ||||
| ROIC | -0.94% | -0.50% | 0.22% | -0.79% |
| Gross Margin | 74.48% | 97.30% | 71.05% | 66.44% |
| Cash Conversion Ratio | -3.19 | -2.94 | -8.58 | -2.17 |
| Growth | ||||
| Revenue 3-Year CAGR | 7.96% | 10.23% | 15.74% | 17.81% |
| Free Cash Flow Growth | -39.60% | 30.54% | 71.42% | -66.03% |
| Safety | ||||
| Net Debt / EBITDA | 8.09 | 6.95 | 6.44 | 7.13 |
| Interest Coverage | -0.80 | -0.45 | 0.20 | -0.87 |
| Efficiency | ||||
| Inventory Turnover | 0.84 | 0.07 | 0.89 | 0.85 |
| Cash Conversion Cycle | -8.13 | -565.95 | 4.54 | 6.70 |